1. Home
  2. PMVP vs BYSI Comparison

PMVP vs BYSI Comparison

Compare PMVP & BYSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PMVP
  • BYSI
  • Stock Information
  • Founded
  • PMVP 2013
  • BYSI 2010
  • Country
  • PMVP United States
  • BYSI United States
  • Employees
  • PMVP N/A
  • BYSI N/A
  • Industry
  • PMVP Medicinal Chemicals and Botanical Products
  • BYSI Biotechnology: Pharmaceutical Preparations
  • Sector
  • PMVP Health Care
  • BYSI Health Care
  • Exchange
  • PMVP Nasdaq
  • BYSI Nasdaq
  • Market Cap
  • PMVP 71.9M
  • BYSI 72.1M
  • IPO Year
  • PMVP 2020
  • BYSI 2017
  • Fundamental
  • Price
  • PMVP $0.88
  • BYSI $1.78
  • Analyst Decision
  • PMVP Strong Buy
  • BYSI
  • Analyst Count
  • PMVP 2
  • BYSI 0
  • Target Price
  • PMVP $5.50
  • BYSI N/A
  • AVG Volume (30 Days)
  • PMVP 165.3K
  • BYSI 32.8K
  • Earning Date
  • PMVP 05-12-2025
  • BYSI 01-01-0001
  • Dividend Yield
  • PMVP N/A
  • BYSI N/A
  • EPS Growth
  • PMVP N/A
  • BYSI N/A
  • EPS
  • PMVP N/A
  • BYSI N/A
  • Revenue
  • PMVP N/A
  • BYSI N/A
  • Revenue This Year
  • PMVP N/A
  • BYSI N/A
  • Revenue Next Year
  • PMVP N/A
  • BYSI N/A
  • P/E Ratio
  • PMVP N/A
  • BYSI N/A
  • Revenue Growth
  • PMVP N/A
  • BYSI N/A
  • 52 Week Low
  • PMVP $0.82
  • BYSI $0.98
  • 52 Week High
  • PMVP $2.26
  • BYSI $3.63
  • Technical
  • Relative Strength Index (RSI)
  • PMVP 33.62
  • BYSI 56.52
  • Support Level
  • PMVP $0.85
  • BYSI $1.64
  • Resistance Level
  • PMVP $1.04
  • BYSI $2.14
  • Average True Range (ATR)
  • PMVP 0.06
  • BYSI 0.17
  • MACD
  • PMVP -0.01
  • BYSI 0.04
  • Stochastic Oscillator
  • PMVP 10.42
  • BYSI 56.63

About PMVP PMV Pharmaceuticals Inc.

PMV Pharmaceuticals Inc is a precision oncology company. The company is engaged in the research and development of small molecule, tumor-agnostic therapies targeting p53 mutations, which has the ability to eliminate cancer cells.

About BYSI BeyondSpring Inc.

BeyondSpring Inc is engaged in clinical-stage biopharmaceutical activities focused on the development of cancer therapies. It is also focused on including immuno-oncology agents. It has two reportable segments Plinabulin pipeline and the TPD platform.

Share on Social Networks: